XML 32 R81.htm IDEA: XBRL DOCUMENT v2.4.0.8
18. Pro Forma Financials for Acquisition of Canterbury and Hygeia (Details A) (USD $)
 3 Months Ended 12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Dec. 31, 2012
Cost of revenues $ 0 $ 0 $ 0 $ 235,803
Gross profit 0 0 71,667 138,739
Operating expenses        
General, administrative, research and development 611,845 624,674 2,008,118 4,570,161
Impairment of intangible assets     1,935,621 1,423,844
Warrants, options and stock 149,885 1,316,148 4,228,317 3,643,662
Fair value of common stock exchanged for warrants     3,069,792 0
Legal and professional services 131,686 143,103 1,071,392 2,128,898
Depreciation and amortization 478,104 8,687 675,757 164,043
Total operating expenses 1,371,520 2,092,612 12,988,997 11,930,608
Loss from operations (1,371,520) (2,092,612) (12,917,330) (11,791,869)
Other (income)/expenses        
(Gain)/loss on adjustments to fair value of derivative liability 0 236,850 (8,980,077) (6,907,748)
Gain on extinguishment of derivative liability     (1,635,967) 0
Other (income)/expense (49,639) (2,564) (71,631) 379,188
Interest expense 58,294 22,971 228,294 167,894
Total other income 8,655 257,257 (10,459,381) (4,942,054)
Net loss (1,380,175) (2,476,780) (2,457,949) (6,849,815)
Net loss attributed to non-controlling interests     (6,401) (19,079)
Net loss attributed to RestorGenex Corporation     (2,464,350) (6,868,894)
Preferred dividends $ 0 $ 124,375 $ 171,625 $ 497,167
Net loss attributable to RestorGenex Corporation common shareholders (1,380,175) (2,601,155) (2,635,975) (7,366,061)
Basic and diluted loss per share $ (0.23) $ (2.91) $ (1.00) $ (8.16)
Pro Forma Adjustments for Canterbury and Hygeia (b)
        
Revenues     127,167  
Cost of revenues     89,387  
Gross profit     37,780  
Operating expenses        
General, administrative, research and development     265,260  
Impairment of intangible assets     0  
Warrants, options and stock     0  
Fair value of common stock exchanged for warrants     0  
Legal and professional services     326,646  
Depreciation and amortization     14,781  
Total operating expenses     606,687  
Other (income)/expenses        
(Gain)/loss on adjustments to fair value of derivative liability     0  
Gain on extinguishment of derivative liability     0  
Other (income)/expense     0  
Interest expense     20,267  
Total other income     20,267  
Net loss     (589,174)  
Net loss attributed to non-controlling interests     0  
Net loss attributed to RestorGenex Corporation     (589,174)  
Preferred dividends     $ 0  
Net loss attributable to RestorGenex Corporation common shareholders     (589,174)  
Other Pro Forma Adjustments
        
Revenues     0  
Cost of revenues     0  
Gross profit     0  
Operating expenses        
General, administrative, research and development     503,732  
Impairment of intangible assets     0  
Warrants, options and stock     0  
Fair value of common stock exchanged for warrants     0  
Legal and professional services     0  
Depreciation and amortization     659,958  
Total operating expenses     1,163,690  
Other (income)/expenses        
(Gain)/loss on adjustments to fair value of derivative liability     0  
Gain on extinguishment of derivative liability     0  
Other (income)/expense     0  
Interest expense     0  
Total other income     0  
Net loss     (1,163,690)  
Net loss attributed to non-controlling interests     0  
Net loss attributed to RestorGenex Corporation     (1,163,690)  
Preferred dividends     $ 0  
Net loss attributable to RestorGenex Corporation common shareholders     (1,163,690)  
Basic and fully-diluted weighted average shares outstanding     1,014,623  
Pro Forma Combined
        
Revenues     198,834  
Cost of revenues     89,387  
Gross profit     109,447  
Operating expenses        
General, administrative, research and development     2,777,110  
Impairment of intangible assets     1,935,621  
Warrants, options and stock     4,228,317  
Fair value of common stock exchanged for warrants     3,069,792  
Legal and professional services     1,398,038  
Depreciation and amortization     1,350,496  
Total operating expenses     14,759,374  
Other (income)/expenses        
(Gain)/loss on adjustments to fair value of derivative liability     (8,980,077)  
Gain on extinguishment of derivative liability     (1,183,093)  
Other (income)/expense     (524,505)  
Interest expense     248,561  
Total other income     (10,439,114)  
Net loss     (4,210,813)  
Net loss attributed to non-controlling interests     (6,401)  
Net loss attributed to RestorGenex Corporation     (4,217,214)  
Preferred dividends     $ 171,625  
Net loss attributable to RestorGenex Corporation common shareholders     (4,388,839)  
Basic and diluted loss per share     $ (1.20)  
Basic and fully-diluted weighted average shares outstanding     3,661,226  
RestorGenex
        
Revenues     71,667  
Cost of revenues     0  
Gross profit     71,667  
Operating expenses        
General, administrative, research and development     2,008,118  
Impairment of intangible assets     1,935,621  
Warrants, options and stock     4,228,317  
Fair value of common stock exchanged for warrants     3,069,792  
Legal and professional services     1,071,392  
Depreciation and amortization     675,757  
Total operating expenses     12,988,997  
Other (income)/expenses        
(Gain)/loss on adjustments to fair value of derivative liability     (8,980,077)  
Gain on extinguishment of derivative liability     (1,183,093)  
Other (income)/expense     (524,505)  
Interest expense     228,294  
Total other income     (10,459,381)  
Net loss     (2,457,949)  
Net loss attributed to non-controlling interests     (6,401)  
Net loss attributed to RestorGenex Corporation     (2,464,350)  
Preferred dividends     $ 171,625  
Net loss attributable to RestorGenex Corporation common shareholders     $ (2,635,975)  
Basic and diluted loss per share     $ (1.00)  
Basic and fully-diluted weighted average shares outstanding     2,646,603